Localization and clinical significance of thyrotropin receptor mRNA expression in orbital fat and eye muscle tissues from patients with thyroid-associated ophthalmopathy

Thyroid

Volumn 6, Issue 6, 1996, Pages 553-562

  Hiromatsu, Yuji ^a   Sato, Masayuki ^a   Inoue, Yoichi ^b   Koga, Mari ^a   Miyake, Ikuyo ^a   Kameo, Junko ^a   Tokisawa, Shiro ^a   Yang, Damu ^a   Nonaka, Kyohei ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Olympia Medical Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THYROTROPIN RECEPTOR;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CHEMISTRY; EYE; EYE DISEASE; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MALE; METABOLISM; MIDDLE AGED; MUSCLE; NORTHERN BLOTTING; ORBIT; POLYMERASE CHAIN REACTION; THYROID DISEASE;

ADIPOSE TISSUE; ADULT; AGED; BLOTTING, NORTHERN; EYE; EYE DISEASES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUSCLES; ORBIT; POLYMERASE CHAIN REACTION; RECEPTORS, THYROTROPIN; RNA, MESSENGER; THYROID DISEASES;

EID: 0030345013     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1996.6.553     Document Type: Article

References (42)

1. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D 1991 Thyroid-associated ophthalmopathy - A model for the association of organ-specific autoimmune disorders. Immunol Today 12:150-153.
2. Weetman AP 1991 Thyroid-associated eye disease: Pathophysiology. Lancet 338:25-28.
3. Gorman CA 1994 Pathogenesis of Graves' ophthalmopathy. Thyroid 4:379-383.
4. Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento EV, Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338.
5. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3:297-300.
6. Mengistu M, Lukses YG, Nagy EV, Burch HB, Carr FE, Lahiri S, Burman KD 1994 TSH receptor gene expression in retroocular fibroblasts. J Endocrinol Invest 17:437-441.
7. Paschke R, Elisei R, Vassart G, Ludgate M 1993 Lack of evidence supporting the presence of mRNA for thyrotropin receptor in extra-ocular muscle. J Endocrinol Invest 16:329-332.
8. Paschke R, Metcalfe A, Alcalde L, Vassart G, Weetman A, Ludgate M 1994 Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues. J Clin Endocrinol Metab 79:1234-1238.
9. Christy JH, Morse RS 1977 Hypothyroid Graves' disease. Am J Med 62:291-296.
10. Yoshikawa K, Higashide T, Nakase Y, Inoue T, Inoue Y, Shiga H 1991 Role of rectus muscle enlargement in clinical profile of dysthyroid ophthalmopathy. Jpn J Ophthalmol 35:175-181.
11. Hiromatsu Y, Fukazawa H, How J, Wall JR 1987 Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy-Roles of class II MHC antigen expression and γ-interferon action on effector and target cells. Clin Exp Immunol 70:597-603.
12. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Anal Biochem 162:156-159.
13. Gross B, Misrahi M, Sar S, Milgrom E 1991 Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun 177:679-687.
14. Graves PN, Tomer Y, Davies TF 1992 Cloning and sequencing of a 1.3 kb variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun 187:1135-1143.
15. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S 1987 Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47:5616-5619.
16. Lerren TP, Rodningen OK, Rosby O, Solberg K, Berg K 1993 Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads. Biotechniques 14:618-723.
17. Tanaka K, Hiromatsu Y, Sato M, Inoue Y, Nonaka K 1994 Localization of heat shock protein in orbital tissue from patients with Graves' ophthalmopathy using in situ hybridization. Life Sci 54:355-359.
18. Hiromatsu Y, Tanaka K, Ishisaka N, Kamachi J, Kuroki T, Hoshino T, Inoue Y, Wall JR, Nonaka K 1995 Human histocompatibility leukocyte antigen-DR and heat shock protein-70 expression in eye muscle tissue in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 80:685-691.
19. Birbuamer L, Rodbell M 1969 Adenyl cyclase in fat cells. II. Hormone receptors. J Biol Chem 244:3477-3482.
20. Hart IR, McKenzie JM 1971 Comparison of the thyrotropin and the long-acting thyroid stimulator on guinea pig adipose tissue. Endocrinol 88:26-30.
21. Teng CS, Rees-Smith B, Anderson J, Hall R 1975 Comparison of thyrotropin receptors in membranes prepared from fat and thyroid tissue. Biochem Biophys Res Commun 66:836-841.
22. Bolonkin D, Tate RL, Luber JH, Kohn LD 1975 Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem 250:6509-6515.
23. Perros P, Kendall-Taylor P 1994 Demonstration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathogenesis of thyroid-associated ophthalmopathy. J Endocrinol Invest 17:163-170.
24. Trokoudes KM, Sugenoya A, Hazani E, Row VV, Volpé R 1979 Thyroid-stimulating hormone (TSH) binding to extrathyroidal human tissues: TSH and thyroid-stimulating immunoglobulin effects on adenosine 3′,5′-monophosphate in testicular and adrenal tissues. J Clin Endocrinol Metab 48:919-923.
25. Pekonen F, Weintraub BD 1978 Thyrotropin binding to cultured lymphocytes and thyroid cells. Endocrinol 103: 1668-1677.
26. Chaband O, Lissitzky S 1977 Thyrotropin-specific binding to human peripheral blood monocytes and polymorphonuclear leucocytes. Mol Cell Endocrinol 7:79-87.
27. Roselli-Rehfuss L, Robbins LS, Cone RD 1992 Thyrotropin receptor messenger ribonucleic acid is expressed in most brown and white adipose tissues in the guinea pig. Endocrinol 130:1857-1861.
28. Endo T, Ohno M, Kotani S, Gunji K, Onaya T 1993 Thyrotropin receptor in non-thyroid tissues. Biochem Biophys Res Commun 190:774-779.
29. Endo T, Ohta K, Haraguchi K, Onaya T 1995 Cloning and functional expression of a thyrotropin receptor cDNA from rat fat cells. J Biol Chem 270:10833-10837.
30. Francis T, Burch HB, Cai W-Y, Lukes Y, Peele M, Carr FE, Wartofsky L, Burman K 1991 Lymphocytes express thyrotropin receptor-specific mRNA as detected by the PCR technique. Thyroid 1:223-228.
31. Burch HB, Sellitti D, arnes SG, Nagy EV, Bahn RS, Burman KD 1994 Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 78:1384-1391.
32. Heufelder AE 1995 Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid 5:331-340.
33. Benker G, Kotulla P, Kendall-Taylor P, Emrich D, Reinwein D 1989 TSH binding-inhibiting antibodies in hyperthyroidism: Relationship to clinical signs and hormone levels. Clin Endocrinol 30:19-28.
34. Wall JR, Strakosch CR, Fang SL, Ingbar SH, Braverman LH 1979 Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: Effect of treatment with cyclophosphamide. Clin Endocrinol 10:79-91.
35. Chang TC, Huang KH, Chang TJ, Lin SL 1990 Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease. Clin Endocrinol 32:551-558.
36. McKenzie JM, McCullagh EP 1968 Observations against a causal relationship between the long-acting thyroid-stimulator and ophthalmopathy in Graves' disease. J Clin Endocrinol Metab 28:1117-1182.
37. Feldt-Rasmussen U, Kemp A, Bech K, Madsen SN, Date J 1981 Serum thyroglobulin, its autoantibody and thyroid stimulating antibodies in the endocrine exophthalmos. Acta Endocrinol 96:192-198.
38. Nishikawa M, Yoshimura M, Toyoda N, Masaki H, Yonemoto T, Gondou A, Kato T, Kurokawa H, Furumura T, Inada M 1993 Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol 129:213-219.
39. Hiromatsu Y, Kojima K, Ishisaka N, Tanaka K, Sato M, Nonaka K, Nishimura H, Nishida H 1992 Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: Its predictive value for therapeutic outcome of immuno-suppressive therapy. Thyroid 2:299-305.
40. Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD 1986 Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: An assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 62:357-367.
41. Paschke R, Vassart G, Ludgate M 1995 Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol 42:565-569.
42. Chelly J, Concordet J-P, Kaplan J-C, Kahn A 1989 Illegitimate transcription: Transcription of any gene in any cell type. Proc Natl Acad Sci USA 86:2617-2621.